Skip to main content

Table 1 Pathologic and genetic features and classification of EBV + T/NK-cell lymphoproliferative disease

From: Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts

No

Diagnosis*

Ohshima category**

Histo

CD4

CD8

CD56

TCR αβ

TCR γδ

TCR PCR

Cell of origin

BM karyotype

1

CAEBV

A1

P

-

-

-

-

-

PC

TCR silent vs NK

N

2

CAEBV

A1

P

-

+

-

+

-

PC

T

N

3

CAEBV

A1

P

-

+

+

-

-

PC

TCR silent vs NK

N

4

STLPDC

A2

P

-

+

-

+

-

MC

T

N

5

STLPDC

A2

P

-

+

-

-

-

MC

T

N

6

STLPDC

A2

P

-

+

-

-

-

MC

T

N

7

STLPDC

A2

P

+

-

+

Focal +

-

MC

T

N

8

CAEBV vs STLPDC

A1 or A2

P

NA

NA

+

NA

NA

NA

NA

NA

9

CAEBV vs STLPDC

A1 or A2

P

-

+

-

NA

NA

NA

NA

NA

10

CAEBV vs STLPDC

A1 or A2

P

+

+

-

NA

NA

NA

NA

NA

11

CAEBV vs STLPDC

A1 or A2

P

NA

NA

-

NA

NA

NA

NA

NA

12

STLPDC

A3

M

-

+

+

Focal +

-

MC

T

Abn

13

STLPDC

A3

M

-

+

-

+

-

MC

T

N

14

STLPDC

B

M

-

+

+

+

-

MC

T

Abn

15

STLPDC

B

M

-

+

-

-

-

MC

T

Abn

16

STLPDC

B

M

+

-

-

Focal +

-

PC

favour T

Abn

17

STLPDC

B

M

-

+

-

+

-

MC

T

N

18

STLPDC

B

M

-

+

-

+

-

MC

T

Mosaic

19

STLPDC

B

M

-

+

-

+

-

NA

T

N

20

STLPDC

B

M

+

-

-

+

NA

PC

T

Abn

21

STLPDC

B

M

-

-

-

NA

NA

NA‡

NA

NA

22

favour STLPDC

A3 or B

M

-

-

+

+

-

NA

T

NA

  1. Abbreviations: Histo histology, M monomorphic, P polymorphic, TCR clonality for T-Cell Receptor Gamma gene by PCR, MC monoclonal, PC polyclonal, Abn abnormal, N normal, NA not available, OS overall survival, BM bone marrow, CAEBV chronic active EBV infection of T-NK type, STLPDC systemic EBV + T cell lymphoproliferative disorder of childhood, EBV + TLPD EBV-positive T cell lymphoproliferative disorder.
  2. ‡EBV terminal repeats analysis revealed monoclonality.
  3. *Based on WHO classification and recommendation from NIH consensus meeting in 2008 [12].
  4. **Based on categorization of EBV + T/NK lymphoproliferative disorders in children by Ohshima et al. [13].